Bio-Techne TECH Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.22B+5.2% | $1.16B+2.0% | $1.14B+2.8% | $1.11B+18.7% | ||
| $429.36M+10.3% | $389.34M+6.1% | $366.89M+5.1% | $349.1M— | ||
| $790.27M+2.7% | $769.73M0.0% | $769.82M+1.8% | $756.5M— | ||
| 64.8%-1.6pp | 66.4%-1.3pp | 67.7%-0.7pp | 68.4%— | ||
| $99.5M+2.9% | $96.66M+4.5% | $92.49M+6.1% | $87.14M— | ||
| $588.52M+26.2% | $466.37M+23.3% | $378.38M+1.5% | $372.77M— | ||
| $688.02M+22.2% | $563.04M+19.6% | $470.87M+2.4% | $459.91M— | ||
| $688.02M+22.2% | $563.04M+19.6% | $470.87M+2.4% | $459.91M— | ||
| —— | $206.69M-30.9% | $298.94M+0.8% | $296.59M— | ||
| $8.51M-45.9% | $15.74M+40.3% | $11.22M-0.8% | $11.31M-18.9% | ||
| $3.89M+16.9% | $3.32M-2.6% | $3.41M+329% | $794K+67.9% | ||
| —— | -$21M— | —— | —— | ||
| —— | $185.69M-45.2% | $338.66M+12.4% | $301.39M— | ||
| —— | $17.59M-67.0% | $53.22M+39.0% | $38.29M— | ||
| —— | $168.11M-41.1% | $285.26M+4.9% | $272.05M+93.9% | ||
| —— | $1.05-40.0% | $1.75-40.3% | $2.93— | ||
| —— | $1.06-41.4% | $1.81-41.0% | $3.07— | ||
| 640.4M-0.4% | 643.3M-0.6% | 647.4M+21.2% | 534M— | ||
| 631.9M+0.2% | 630.7M+0.4% | 628.4M+23.2% | 510.3M— | ||
| $3.89M+16.9% | $3.32M-2.6% | $3.41M— | —— | ||
| $91.84M-41.1% | $155.85M-47.1% | $294.4M+15.8% | $254.14M— | ||
| -$5.57M-16.9% | -$4.76M-199% | $4.79M-66.4% | $14.26M— | ||
| $18.44M+250% | -$12.25M-235% | $9.1M+151% | -$17.98M-145% | ||
| $831K+110% | -$8.58M-118% | $47.52M+210% | $15.31M+120% | ||
| $99.5M+2.9% | $96.66M+4.5% | $92.49M+6.1% | $87.14M— | ||
| $1.22B+5.2% | $1.16B+2.0% | $1.14B+2.8% | $1.11B+18.7% | ||
| —— | $206.69M-30.9% | $298.94M+0.8% | $296.59M— | ||
| —— | $318.4M-21.6% | $406.18M+2.1% | $397.66M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Techne's revenue?
- Bio-Techne (TECH) generated $1.2B in revenue over the trailing twelve months, up 0.2% year over year.
- Is Bio-Techne profitable?
- Bio-Techne reported $149.8M in net income over the trailing twelve months, a 10.9% net margin.
- What are Bio-Techne's profit margins?
- Gross margin is 65.0% and operating margin is 14.2%, with a 10.9% net margin.
- What is Bio-Techne's earnings per share?
- Bio-Techne's diluted EPS over the trailing twelve months is $0.94.
- Where does Bio-Techne's income statement data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
